UNSPSC 51384619: Trifezolac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XJ3W180C22. European Medicines Agency schedules Trifezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11283MIG. Trifezolac generally arises in the molecular formula C23H18N2O2.

UNSPSC 51384619 Trifezolac is a Commodity code nominally covering a specific pharmaceutical product, but recent state and local procurement activity under this code shows a significant mismatch — the sole recent opportunity posted under the code involves naloxone and safe drug deactivation systems, not trifezolac. Seminole County, Florida issued an IFB (Invitation for Bid) in mid-2023 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the county's community health building. The solicitation required vendors to submit bids through the county's e-Procurement Portal, include all shipping and delivery costs in proposals, and comply with drug-free workplace certification, E-Verify verification, and standard insurance requirements. The contract included a two-year initial term with a one-year renewal option and featured a three-month probationary period allowing termination with or without cause. The procurement carried potential FEMA funding, introducing compliance obligations under federal environmental regulations.

The available recent-opportunities block contains only the single Seminole County solicitation, which suggests minimal current state and local procurement activity under this code or a persistent categorization error in how the code has been applied to opportunities in the market. The geographic and issuing-body scope cannot be reliably characterized from one opportunity. Business development professionals should verify whether trifezolac procurement does occur under this code in practice, or whether opportunities tagged to 51384619 consistently reflect pharmaceutical and harm-reduction products outside the nominal code scope. If the code has been systematically misapplied to naloxone and deactivation-system buys, the actual buying activity may be concentrated in public health departments and counties in Florida and elsewhere, but the source does not support a confident geographic or buyer-type characterization at this time.